BioSpace News Archive

Increasing demand for surgical procedures and integration of highly compatible materials into the clips are forecasted to drive the market growth.

The medical collagen market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

The pre-filled saline syringes market accounted to US$ 402.5 Mn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 - 2027, to account to US$ 744.4 Mn by 2027.

The subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018.

MiRus™ announced today that Mark Faucett has joined the company’s Leadership Team as Vice President of Business Development effective June 1, 2021.

Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT™, announced today that the first participant in its US pilot trial for skin cancer has been treated with Alpha DaRT, at University Cancer Center in Houston, Texas

The global Life Sciences Tools market accrued earnings worth approximately 93.1(USD Billion) in 2020 and is predicted to gain revenue of about 128.7(USD Billion) by 2028, is set to record a CAGR of nearly 12.2% over the period from 2021 to 2028.

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”) today announced it has entered into a Clinical Trial Collaboration and Supply Agreement (“Agreement”) with Merck (known as MSD outside the United States and Canada) to evaluate the combination of OncoSec’s DNA-plasmid interleukin-12 (IL-12) TAVO™

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2021, after the market closes on Monday, July 26, 2021.

XBiotech Inc.’s (NASDAQ: XBIT) (“XBiotech”) Board of Directors has declared an extraordinary cash dividend of approximately $2.50 per share, or up to an aggregate of $75 million, to holders of its common stock